id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2686809,b9014dc0-e00a-4d03-9e69-61f96b4ce868,Q3,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,AIPHARMA GLOBAL HOLDINGS LIMITED,2021,third_quarter,HCR,Issues related to the pharmaceutical supply chain,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",80000,,0,0,2021-10-18T17:28:08.097000-04:00
2686810,b9014dc0-e00a-4d03-9e69-61f96b4ce868,Q3,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,AIPHARMA GLOBAL HOLDINGS LIMITED,2021,third_quarter,PHA,Issues related to the pharmaceutical supply chain,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",80000,,0,0,2021-10-18T17:28:08.097000-04:00